Pharma News

Fresenius Kabi signs marketing agreement for adalimumab biosimilar

Home/Pharma News | Posted 05/06/2020

German pharmaceutical company Fresenius Kabi has signed an agreement with methotrexate supplier Medac for the sale of its adalimumab biosimilar Idacio. The agreement is likely to boost sales of Idacio.

Success for Celltrion in Japan and Samsung Bioepis in Europe

Home/Pharma News | Posted 29/05/2020

South Korean biosimilar manufacturer Celltrion’s trastuzumab biosimilar has gained a 40% market share in Japan. Meanwhile, Samsung Bioepis, which is also headquartered in South Korea, announced European sales in excess of US$200 million in the first quarter of 2020.

Canadian firm Bausch + Lomb signs agreement on Lucentis biosimilar

Home/Pharma News | Posted 22/05/2020

Canadian eye health specialists Bausch + Lomb have signed an exclusive licensing agreement with Stada and its development partner Xbrane to develop and commercialize a Lucentis biosimilar in Canada and the US.

Mycenax sells tocilizumab biosimilar to Richter

Home/Pharma News | Posted 08/05/2020

Taiwanese biosimilars developer Mycenax announced on 28 April 2020 that it had made a deal with Hungary-based Gedeon Richter (Richter) regarding its tocilizumab biosimilar.

Dr Reddy’s buys Wockhardt plant and Strides acquires 18 ANDAs

Home/Pharma News | Posted 10/04/2020

Dr Reddy’s Laboratories (Dr Reddy’s) is to acquire US$260 million worth of Wockhardt’s business including a major manufacturing facility in India, while Strides is to acquire 18 abbreviated new drug applications (ANDAs) for the US market.

FDA’s response to coronavirus

Home/Pharma News | Posted 03/04/2020

In response to the coronavirus pandemic, the US Food and Drug Administration (FDA) has issued a comprehensive statement regarding effects on the supply chain and inspections of plants overseas.

Roche continues litigation in India and receives fine in Romania

Home/Pharma News | Posted 27/03/2020

Switzerland-based pharmaceutical giant Roche is continuing to pursue legal action in India over a trastuzumab similar biologic and has recently been fined in Romania for delaying the entry of biosimilars to the market.

New biosimilars partnerships from Alvotech and Biocon

Home/Pharma News | Posted 13/03/2020

Alvotech has formed an exclusive partnership with JAMP Pharma (JAMP) for the commercialization of its biosimilars in Canada, while Biocon has expanded its collaboration with Equillium to include Australia and New Zealand.

Amgen to buy out Japanese partner Astellas

Home/Pharma News | Posted 06/03/2020

US-based biotech giant Amgen has announced that it will dissolve its joint venture with the Japanese company Astellas in order to operate the unit independently. This means Astellas will become a wholly-owned Amgen affiliate.

Celltrion to build facility in China and increase new drug output

Home/Pharma News | Posted 28/02/2020

South Korean biotechnology company Celltrion has announced plans to build its first overseas factory in China. The company also intends to release one new biosimilar per year until 2030.